Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial.
Bruna CL, van Hilst J, Korrel M, Jones LR, Balzano G, Björnsson B, Boggi U, Bratlie SO, Busch OR, Butturini G, Capretti G, Casadei R, Dokmak S, Edwin B, Esposito A, Falconi M, Ferrari G, Hackert T, Kazemier G, Koerkamp BG, de Kleine RH, Keck T, Kleive DB, Kokkola A, Kooby D, Lips DJ, Luyer MDP, Guerra M, Marudanayagam R, Menon K, Molenaar IQ, de Pastena M, Pecorelli N, Primrose JN, Ricci C, Saint Marc O, Salvia R, Sandström P, Tomazic A, Wellner UF, Yip VS, Zerbi A, Ali M, Dijkgraaf MGW, Besselink MG, Abu Hilal M; European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS).
Bruna CL, et al. Among authors: esposito a.
JAMA Surg. 2025 Dec 1;160(12):1299-1307. doi: 10.1001/jamasurg.2025.4054.
JAMA Surg. 2025.
PMID: 41060640
Clinical Trial.